###begin article-title 0
CD28 Co-Stimulation Down Regulates Th17 Development
###end article-title 0
###begin p 1
Conceived and designed the experiments: SB NB MS. Performed the experiments: SB GF NB MR. Analyzed the data: SB GF NB MR MS. Wrote the paper: SB GF MS.
###end p 1
###begin p 2
###xml 339 340 339 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 679 680 675 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 187 193 <span type="species:ncbi:10090">murine</span>
###xml 923 929 <span type="species:ncbi:10090">murine</span>
###xml 934 939 <span type="species:ncbi:9606">human</span>
###xml 1162 1167 <span type="species:ncbi:9606">human</span>
Th17 cells are implicated in host defence and autoimmune diseases. CD28/B7 co-stimulation is involved in the induction and progression of autoimmune diseases, but its role in controlling murine Th17 cell fate remains to be clarified. We here report that soluble anti-CD28 mAb suppressed the differentiation of anti-CD3-stimulated naive CD4+ T cells into IL-17-producing cells. CD28 co-stimulation reduced the frequency of proliferating cells that produce IL-17. We provide evidence for an IL-2 and IFN-gamma-dependent mechanism of CD28-mediated IL-17 suppression. CD28 blockade of Th17 development was correlated with a decrease rather than an increase in the percentage of Foxp3+ T cells. In APC/T cell co-cultures, mature dendritic cells (DC) were less efficient than immature DC in their ability to support Th17 cell differentiation, while CTLA4-Ig, an agent blocking CD28/B7 and CTLA4/B7 interactions, facilitated both murine and human Th17 differentiation. This study identifies the importance of B7 co-stimulatory molecules in the negative regulation of Th17 development. These unexpected results caution targeting the CD28/B7 pathways in the treatment of human autoimmune diseases.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 101 104 101 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Matusevicius1">[1]</xref>
###xml 132 135 132 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Ziolkowska1">[2]</xref>
###xml 156 159 156 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Fujino1">[3]</xref>
###xml 244 315 244 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Klebseilla pneumoniae, Staphylococcus aureus, Mycobacteria tuberculosis</italic>
###xml 320 336 320 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 336 339 336 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Bettelli1">[4]</xref>
###xml 531 539 519 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 812 815 783 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Park1">[5]</xref>
###xml 817 820 788 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Bettelli2">[6]</xref>
###xml 822 825 793 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Mangan1">[7]</xref>
###xml 827 830 798 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Veldhoen1">[8]</xref>
###xml 832 835 803 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Weaver1">[9]</xref>
###xml 931 935 899 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Korn1">[10]</xref>
###xml 978 979 946 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1298 1302 1266 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Sharpe1">[11]</xref>
###xml 1304 1308 1272 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Salomon1">[12]</xref>
###xml 1310 1314 1278 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Egen1">[13]</xref>
###xml 1717 1721 1685 1689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Racke1">[14]</xref>
###xml 1723 1727 1691 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Perrin1">[15]</xref>
###xml 1889 1893 1857 1861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Salomon1">[12]</xref>
###xml 1895 1899 1863 1867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Lohr1">[16]</xref>
###xml 2007 2011 1975 1979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Lenschow1">[17]</xref>
###xml 267 288 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 320 336 <span type="species:ncbi:5476">Candida albicans</span>
###xml 563 569 <span type="species:ncbi:10090">murine</span>
###xml 1967 1971 <span type="species:ncbi:10090">mice</span>
Th17 cells play a central role in autoimmune inflammatory conditions such as multiple sclerosis (MS) [1], rheumatoid arthritis (RA) [2] and Crohn's disease [3]. Th17 cells are also involved in the protection against several pathogens including Klebseilla pneumoniae, Staphylococcus aureus, Mycobacteria tuberculosis and Candida albicans[4]. These cells are characterised by the expression of the transcription factor RORgammat and the production of the cytokines IL-17, IL-22, IL-6 and tumor necrosis factor-alpha (TNF-alpha). The in vitro differentiation of the murine Th17 cell lineage depends on the synergy between transforming growth factor-beta (TGF-beta) and IL-6, combined with the neutralization of IFN-gamma and IL-4. TNF-alpha and IL-1beta act as amplifiers, while IL-23 stabilizes the Th17 phenotype [5], [6], [7], [8], [9]. The combination of TGF-beta and IL-21 constitutes an alternative pathway for Th17 development [10]. The activation and differentiation of CD4+ T helper lymphocytes into Th1 or Th2 cells requires both T cell receptor/MHC-peptide specific recognition and co-stimulatory signals. The best-defined co-stimulatory pathway involves the B7 family, where B7.1 (CD80) and B7.2 (CD86) molecules on antigen presenting cells interact with CD28 and CD152 (CTLA4) on T cells [11], [12], [13]. However, the precise role of these co-stimulatory molecules in the regulation of Th17 development remains unclear. The rationale for assessing the role of CD28 signalling in Th17 differentiation stemmed from reports demonstrating that treatment of experimental autoimmune encephalomyelitis (EAE) with anti-CD80 or anti-CD86 Abs or multiple injections of CTLA4-Ig resulted in enhanced disease severity [14], [15]. Additionally, B7 deficiency facilitates autoimmunity, and this, among other possible mechanisms, was attributed to a loss or inactivation of regulatory T cells [12], [16]. Moreover, the development of diabetes in Non-obese Diabetic (NOD) mice is exacerbated by deletion of CD28 [17].
###end p 4
###begin p 5
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-AmezcuaGuerra1">[18]</xref>
###xml 365 373 365 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 111 118 <span type="species:ncbi:9606">patient</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 331 336 <span type="species:ncbi:10090">mouse</span>
###xml 341 346 <span type="species:ncbi:9606">human</span>
Finally, the clinical report of the development of ulcerative colitis during CTLA4-Ig (abatacept) therapy in a patient with RA reinforces our hypothesis that costimulatory molecules may regulate human Th17 development [18]. We here demonstrate that CD28 signalling suppresses Th17 differentiation, while CTLA4-Ig blockade promotes mouse and human Th17 polarization in vitro.
###end p 5
###begin title 6
Materials and Methods
###end title 6
###begin title 7
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 7
###begin p 8
###xml 29 33 <span type="species:ncbi:10090">mice</span>
All 8- to 12-week-old BALB/c mice were housed in our breeding colony and animal care facility under specific pathogen-free conditions. All experimental protocols were approved by the Centre de Recherche du Centre Hospitalier Universitaire de Montreal (CRCHUM) and the Canadian Council on Animal Care.
###end p 8
###begin title 9
Culture medium, Antibodies and Reagents
###end title 9
###begin p 10
###xml 286 292 282 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.Coli</italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 119 125 <span type="species:ncbi:9913">bovine</span>
###xml 360 365 <span type="species:ncbi:10090">mouse</span>
###xml 393 398 <span type="species:ncbi:9606">human</span>
###xml 477 482 <span type="species:ncbi:10090">mouse</span>
###xml 499 505 <span type="species:ncbi:10090">murine</span>
###xml 915 920 <span type="species:ncbi:10090">mouse</span>
###xml 976 981 <span type="species:ncbi:10090">mouse</span>
###xml 1074 1079 <span type="species:ncbi:10090">mouse</span>
###xml 1105 1110 <span type="species:ncbi:10090">mouse</span>
###xml 1129 1134 <span type="species:ncbi:10090">mouse</span>
###xml 1256 1261 <span type="species:ncbi:10090">mouse</span>
###xml 1294 1299 <span type="species:ncbi:10090">mouse</span>
###xml 1357 1362 <span type="species:ncbi:10090">mouse</span>
###xml 1431 1437 <span type="species:ncbi:10090">murine</span>
###xml 1453 1458 <span type="species:ncbi:10090">mouse</span>
###xml 1555 1560 <span type="species:ncbi:10090">mouse</span>
Mouse cells were cultured in complete RPMI-1640 medium (Wisent Inc., St-Bruno, QC, Canada) supplemented with 10% fetal bovine serum (FBS), Penicillin (500 U/ml), Streptomycin (500 microg/ml), HEPES buffer (10 mM), and 2-ME (1 mM), (GIBCO-BRL, Invitrogen corp., Carlsbad, CA, USA). LPS (E.Coli) was obtained from Sigma-Aldrich (St. Louis, MO, USA). Recombinant mouse IL-1, IL-6 and recombinant human TGF-beta1 were purchased from R&D Systems (Minneapolis, MN, USA). Recombinant mouse GM-CSF and anti-murine IL-2 were purchased from PeproTech (Rocky Hill, NJ, USA). Mitomycin-C was purchased from EMD Chemicals (Gibbstown, NJ, USA). The following clones were purchased from American Type Culture Collection (Rockville, MD, USA) and purified in our laboratory: GK1.5 (anti-CD4, biotinylated); R46A2 (anti-IFN-gamma); 11B11 (anti-IL-4), IM7.8.1 (anti-CD44, biotinylated). Allophycocyanin, FITC or PerCP-conjugated anti-mouse CD4, PerCP-conjugated streptavidin, PE-conjugated anti-mouse CD40, CD86 and IA/IE, allophycocyanin-conjugated Annexin V, allophycocyanin-conjugated anti-mouse IL-2 and IFN-gamma, anti-mouse CD28 and purified mouse CTLA4-Ig fusion protein were purchased from BD Biosciences (Mississauga, ON, CA). PE- or allophycocyanin-conjugated anti-mouse IL-17A, APC/Cy7-conjugated anti-mouse CD25, APC/Cy7 or PE/Cy7-conjugated streptavidin and anti-mouse CD3 were purchased from Biolegend (San Diego, CA, USA). Recombinant murine IL-23 and anti-mouse Foxp3-PE staining kits were purchased from eBioscience (San Diego, CA, USA). PE-conjugated anti-mouse CD62L was purchassed from Caltag Laboratories (Burlingame, CA, USA). Carboxyfluorescein diacetate succinimidyl ester (CFSE) was purchased from Invitrogen (Carlsbad, CA, USA).
###end p 10
###begin title 11
###xml 22 30 22 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Cell purification and in vitro generation of Th17 cells
###end title 11
###begin p 12
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 283 284 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 289 293 289 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 297 300 297 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 312 313 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 323 324 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 330 334 330 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 338 341 338 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 345 346 345 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 362 363 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 368 369 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 373 376 373 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 380 384 380 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 546 547 546 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1170 1171 1147 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1184 1185 1161 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1189 1190 1166 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1198 1199 1175 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1203 1204 1180 1181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1304 1305 1281 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1451 1452 1428 1429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1456 1457 1433 1434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1471 1472 1448 1449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1528 1529 1505 1506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1533 1534 1510 1511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1563 1564 1540 1541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1568 1569 1545 1546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1574 1575 1551 1552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 595 600 <span type="species:ncbi:10090">mouse</span>
###xml 792 797 <span type="species:ncbi:10090">mouse</span>
###xml 878 883 <span type="species:ncbi:10090">mouse</span>
###xml 1295 1300 <span type="species:ncbi:10090">Mouse</span>
###xml 1344 1349 <span type="species:ncbi:10090">mouse</span>
###xml 1723 1728 <span type="species:ncbi:10090">mouse</span>
Total CD4+ T cells were purified from spleen and peripheral lymph nodes (LNs) by positive selection using immunomagnetic beads according to the manufacturer's protocol (EasySep Biotin Selection Kit, StemCell Technologies Inc, Vancouver, BC, CA). For some experiments, naive CD4+ (CD4+CD62LhighCD44low), naive CD4+CD25- (CD4+ CD62LhighCD44lowCD25-) and memory CD4+ (CD4+CD62lowCD44high) T cells were isolated from splenocytes and peripheral lymph nodes (LNs) by sorting using a Becton Dickinson FACSAria II cell sorter (BD Bioscience). Cells (1x106 cells/ml) were activated with plate-bound anti-mouse CD3 (5 or 10 microg/ml) in flat bottom 96-well plates in the presence of the Th17-promoting cytokine cocktail IL-1-alpha, IL-6, IL-23 (10 ng/ml) and TGF-beta1, (1 ng/ml) with or without anti-mouse CD28 mAb (2 microg/ml). For some experiments, 10 microg/ml of neutralizing anti-mouse antibodies (anti-IL-2, anti-IFN-gamma and anti-IL-4) were added to the cultures. After 4-5 days, recovery of viable cells was assessed by trypan blue (GIBCO-BRL, Invitrogen corp.) exclusion. The cells were restimulated during 6 h with PMA/ionomycin. For Treg cell experiments, total CD4+ T cells, CD4+CD25- and CD4+CD25+ T cells were separated from spleen or peripheral LNs using the EasySep Negative Selection Mouse CD4+ T cell Enrichment Kit followed by the mouse CD25-Microbeads Kit (Miltenyi Biotec, Auburn, CA, USA) according to the manufacturer's protocols. CD4+CD25- T cells (1x106 cells/ml) were cultured alone or in the presence of CD4+CD25+ T cells at two different CD4+CD25-/CD25+ ratios (1/1, 4/1) for 4-5 days and activated on anti-CD3 (10 microg/ml) coated plates under Th17 conditions in the presence or the absence of anti-mouse CD28 mAb.
###end p 12
###begin title 13
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Culture of CD4+ T cells with BMDC
###end title 13
###begin p 14
###xml 69 73 69 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Van1">[19]</xref>
###xml 218 219 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 235 236 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 472 473 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 659 660 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 598 603 <span type="species:ncbi:10090">mouse</span>
Bone marrow-derived DC (BMDC) were generated as described previously [19]. In some experiments, BMDC were activated overnight with 1 microg/ml of LPS (mBMDC) and stained for CD86, CD40, or MHCII (IA/IE) expression. CD4+ T cells (2.5x105 cells/ml) were purified from spleens as described and stimulated with soluble (2 microg/ml) or coated anti-CD3 (5 microg/ml) in the presence of immature (untreated) or mature (treated with LPS) mitomycin-C-treated BMDC at different CD4+/BMDC ratios (2/1, 1/1, 1/2). The cultures were supplemented with the Th17 promoting cytokine cocktail. In some experiments, mouse CTLA4-Ig (20 microg/ml) fusion protein was added to CD4+/mBMDC cultures.
###end p 14
###begin title 15
Intracellular cytokine staining
###end title 15
###begin p 16
###xml 199 200 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
For intracellular staining, cells were restimulated for 6 h with PMA (phorbol 12-myristate 13-acetate (PMA, 10 ng/ml) and ionomycin (1 microg/ml) in the presence of brefeldin A (1 microg/ml) per 1x106 cells. Cells were stained in the presence of Fcgamma Blocker (Clone 24G2) with FITC, PerCP or allophycocyanin-conjugated anti-CD4 antibodies, fixed and permeabilized (BD Cytofix/Cytoperm, BD Biosciences or eBioscience for Foxp3 staining). Cells were assessed for IL-17, IFN-gamma, IL-2 and Foxp3 expression. Data were acquired on a Becton Dickinson FACS Calibur and analyzed with Cell Quest software (BD Bioscience).
###end p 16
###begin title 17
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
Labeling Naive CD4+CD25- T cells with CFSE
###end title 17
###begin p 18
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 26 30 26 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 196 197 196 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 262 263 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 521 522 517 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 526 527 522 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 541 542 537 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 614 619 <span type="species:ncbi:10090">mouse</span>
###xml 667 672 <span type="species:ncbi:10090">mouse</span>
Naive CD4+CD25- (CD4+CD62LhighCD44lowCD25-) T cells were isolated from splenocytes and peripheral lymph nodes (LNs) by sorting using a Becton Dickinson FACSAria II cell sorter (BD Bioscience). CD4+ T cells were washed and resuspended at final concentration of 107/mL in EasySep buffer (PBS containing 2% FBS and 1 mM EDTA). CFSE was added at a final concentration of 1 microM and incubated for 15 min at 37 degree. The reaction was stopped by washing cells twice with RPMI 1640, containing 10% FBS. CFSE-labeled naive CD4+CD25- T Cells (1x106 cells/ml) were activated as previously described with plate-bound anti-mouse CD3 under Th17 conditions with or without anti-mouse CD28 mAb. The cells were monitored on day 4-5 for CFSE cell dilution and cytokine expression.
###end p 18
###begin title 19
Assessment of apoptosis
###end title 19
###begin p 20
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 301 302 297 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 315 316 311 312 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 325 326 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
The CD4+ cells were stimulated as described with anti-CD3 in the absence or presence of anti-CD28, harvested from cultures at 48 h, 72, 96 and 120 h, to monitor apoptosis. Briefly, cells were washed and resuspended in 100 microl of Annexin binding buffer (10 mM HEPES, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2) at 1x106/ml with 5 microl of allophycocyanin-conjugated Annexin V (BD Biosciences) and incubated 5 minutes at room temperature. The samples were then analyzed by flow cytometry.
###end p 20
###begin title 21
ELISA
###end title 21
###begin p 22
###xml 112 117 <span type="species:ncbi:10090">Mouse</span>
The production of IL-17 and IFN-gamma was measured with the IL-17 Duoset ELISA kit (R&D Systems) and the OptEIA Mouse IFN-gamma ELISA set (BD Biosciences), respectively, according to the manufacturer's protocols.
###end p 22
###begin title 23
Quantitative RT-PCR analysis
###end title 23
###begin p 24
Total RNA was extracted from cell cultures using the RNeasy mini kit (Qiagen, Mississauga, ON) and reverse-transcribed using the cDNA reverse transcription kit (Applied Biosystems, Foster City, CA). Quantitative real-time PCR was performed using an ABI Prism 7900HT Sequence Detection System (Applied Biosystems) (1 PCR cycle, 95degreesC, 10 minutes; 40 PCR cycles, 60degreesC, 1 minute, 95degreesC, 15 seconds). cDNA was amplified in a 10 microl final reaction mix containing TaqMan Universal PCR Master Mix (Applied Biosystems) and corresponding TaqMan(R) Gene Expression Assays (Mm00444241_m1 (IL-22), Mm00439619_m1 (IL-17a), Hs99999901_s1 (Eukaryotic 18s rRNA), Applied Biosystems). Signals were analyzed by the ABI Prism Sequence Detection System software version 2.2 (Applied Biosystems). The comparative Ct method for relative quantification was used, whereby all threshold cycles (Ct) are first normalized to the expression of an endogenous control (18s rRNA). The normalized values were then divided by the average delta Ct value of anti-CD3-stimulated samples. Here, the cytokine expression is represented as a fold-change relative to CD3-stimulated cells+/-SEM.
###end p 24
###begin title 25
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human DC/T co-cultures
###end title 25
###begin p 26
###xml 132 133 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 276 277 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 298 299 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 305 306 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 342 343 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 399 400 399 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 261 266 <span type="species:ncbi:9606">human</span>
###xml 579 584 <span type="species:ncbi:9606">human</span>
###xml 691 696 <span type="species:ncbi:9606">human</span>
Human PBMC were obtained from healthy volunteers in compliance with the Institutional (CR-CHUM) Research Ethics Committee. Naive CD4+ T were isolated from total PBMC using the human CD4+ Naive T cell Enrichment Kit (Stem Cell Technologies). The purity of adult human naive CD4+ T cells was >99% CD4+CD45RA+ and comprised <0.5% single CD45RORA+ cells as assessed by flow cytometry analysis. Naive CD4+ T cells were co-cultured for 5 days with mature monocyte-derived DC at a DC/T ratio of 1/25 in Yssel's medium (Gemini Bio-product, West-Sacramento, CA, USA) supplemented with 2% human AB serum (Wisent) in the presence of 100 ng/ml of soluble anti-CD3 (OKT-3; Janssen-Ortho) with or without human CTLA4-Ig fusion protein (5 microg/ml) (Abatacept, Orencia, Bristol-Myers Squibb, Canada) for 5 days. Primed T cells were expanded for 5 days in the presence of IL-2 (20 U/ml, R&D Systems). T cells were restimulated for 6 h with PMA (5 ng/ml) and ionomycin (0.5 microg/ml) in the presence of monensin (3 microM). Intracytoplasmic staining was performed using BD Cytofix/Cytoperm and anti-IL-17-APC (R&D System). Culture supernatants were collected after re-stimulation and IL-17, IL-22 and IFN-gamma were detected by ELISA (R&D Systems).
###end p 26
###begin title 27
Statistical Analysis
###end title 27
###begin p 28
Statistical analyses were performed using the GraphPad Instat program.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 75 76 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 81 85 81 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 89 92 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
CD28 co-stimulation negatively regulates the development of naive CD4+ (CD4+CD62LhighCD44low) T cells into IL-17-producing T helper cells
###end title 30
###begin p 31
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 527 533 527 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g001">Fig. 1</xref>
###xml 611 612 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 717 723 717 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g001">Fig. 1</xref>
###xml 1006 1013 996 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g001">Fig. 1C</xref>
###xml 1122 1129 1112 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g001">Fig. 1D</xref>
###xml 1141 1142 1131 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1195 1196 1173 1174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1201 1205 1179 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1209 1212 1187 1190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 1249 1250 1215 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1255 1258 1221 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 1525 1532 1491 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g002">Fig. 2A</xref>
###xml 1698 1705 1664 1671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 1785 1786 1751 1752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1789 1790 1755 1756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1836 1843 1802 1809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g002">Fig. 2A</xref>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
We here hypothesised that the CD28/B7 co-stimulatory pathway controls Th17 development. We first examined the effect of anti-CD28 mAb on Th17 differentiation and cytokine mRNA expression. CD4+ T cells isolated from the spleen or peripheral LNs of wild-type BALB/c mice were activated on plate-bound anti-CD3 under Th17 polarizing conditions in the presence or absence of soluble anti-CD28 mAb. After 4-5 days of primary culture, cells were re-stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin. As depicted in Fig. 1, anti-CD28 mAb strongly inhibited IL-17 production by anti-CD3 stimulated CD4+ T cells as determined by intracellular cytokine staining and enzyme-linked immunosorbent assay (ELISA) (Fig. 1, A-B and data not shown). Accordingly, anti-CD28 mAb diminished the proportion of IL-17-producing cells by 82.8% (mean inhibition+/-8.1%, n = 14). In contrast, IFN-gamma production was significantly increased as reflected by a decreased IL-17/IFN-gamma ratio after CD28 engagement (Fig. 1C). Quantitative real-time PCR (qRT-PCR) analysis of mRNA revealed a reduction in IL-17 and IL-22 expression (Fig. 1D). Since CD4+ T cells are comprised of approximately90% naive (CD4+CD62LhighCD44low) and approximately10% of memory (CD4+CD62Llow) T cells, we next compared naive and memory T cells for their ability to differentiate into Th17 in the presence or absence of CD28 mAb. We showed that CD28 engagement strongly inhibited naive T cell differentiation into Th17 without preventing their proliferation (Fig. 2A). Indeed, IL-17 was exclusively produced by dividing cells and CD28 co-stimulation decreased the proportion of proliferating cells that produced IL-17. In contrast, ex vivo isolated memory T cells represented a minor source of IL-17 (less than 2% IL-17+CD4+ T cells) that was not modulated by CD28 mAb (Fig. 2A). Under Th17 polarizing conditions, memory T cells produced large amounts of IFN-gamma when compared to naive T cells.
###end p 31
###begin title 32
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
CD28 co-stimulation inhibits in vitro generation of IL-17 producing CD4+ T cells.
###end title 32
###begin p 33
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 21 22 21 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 419 420 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 630 631 620 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 644 645 630 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 661 662 647 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 743 744 729 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 899 900 883 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Purified CD4+ T (1x106) cells from spleen (A-C) and LNs (A) were stimulated with plate-bound anti-CD3 with or without anti-CD28 under pro-Th17 conditions for 4-5 days and restimulated for 6 h with PMA/Ionomycin in the presence of brefeldin A. (A) CD4+ T cells were stained intracellularly for IL-17 and IFN-gamma. Numbers represent the percentage of events in each quadrant. (B) Cumulative data of the percentage of CD4+IL-17 and IFN-gamma positive T cells after restimulation as assessed by intracytoplasmic staining. Data represent the mean+/-SEM of at least ten independent experiments. (C) The ratio of the percentage of IL-17+ to IFN-gamma+ cells among CD4+ T cells. (D) qRT-PCR analysis of IL-17 and IL-22 mRNA expression in purified CD4+ T cells cultured as described in A. Data are expressed as mean+/-SEM of four experiments. P values were calculated using the two-tailed, paired Student's t test, *, P<0.05; ***, P<0.001.
###end p 33
###begin title 34
CD28 co-stimulation did not modulate memory Th17 cells.
###end title 34
###begin p 35
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 37 41 37 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 91 95 91 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 99 102 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 106 107 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 123 124 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 135 138 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 142 146 142 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 337 338 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 636 637 634 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 940 941 936 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1029 1030 1021 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1034 1035 1026 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1175 1176 1167 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
(A) FACS sorted naive CD4+ (CD4+CD62LhighCD44low), CFSE-labeled naive CD4+ CD25- (CD4+CD62LhighCD44lowCD25-) and memory CD4+ (CD4+CD62LlowCD44high) T cells were cultured with anti-CD3 in the presence or absence of anti-CD28 mAb under pro-Th17 conditions for 4-5 days. Shown is one representative experiment out of at least three. (B) CD4+ T cells were stimulated with anti-CD3 under Th17 polarizing conditions for 4-5 days and restimulated with plate-bound anti-CD3 in the presence or absence of IL-23, and with or without anti-CD28 mAb for 2 days. Data represent the mean+/-SD of five to seven independent experiments. (C) Purified CD4+ T cells were cultured with anti-CD3 in the presence or absence of anti-CD28 mAb without adding Th17 differentiation cytokines for 4-5 days. Data are the mean+/-SD of 2 independent experiments. (A-C) Cells were restimulated for 6 h with PMA/Ionomycin in the presence of brefeldin A. Naive and memory CD4+ T cells were stained intracellularly for IL-17 and IFN-gamma and CFSE-labeled naive CD4+CD25- for Il-17. Numbers represent the percentage of positive cells in each gate. P value were calculated using the two-tailed, paired Student's t test, **, P<0.01; ***, P<0.001.
###end p 35
###begin p 36
###xml 171 172 171 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 529 536 529 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g002">Fig. 2B</xref>
###xml 574 575 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 784 791 780 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g002">Fig. 2C</xref>
###xml 843 844 839 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
We next verified whether CD28 engagement further regulates T cells that have been differentiated into Th17 with anti-CD3 in the absence of co-stimulation. To this end, CD4+ T cells activated during 4-5 days with coated anti-CD3 under Th17 conditions were restimulated with anti-CD3 and IL-23 in the presence or absence of anti-CD28 mAb. Interestingly, we found that anti-CD28 mAb significantly enhanced IL-17 production upon re-stimulation, demonstrating that CD28 co-stimulation did not inhibit fully differentiated Th17 cells (Fig. 2B). As expected, anti-CD3-activated CD4+ T cells were not polarized into Th17 cells in the absence of the pro-Th17 cocktail, but instead resulted in the development of IFN-gamma-producing T cells, which was further augmented by CD28 co-stimulation (Fig. 2C). We conclude that anti-CD28 mAb inhibits naive CD4+ T cells polarization into Th17.
###end p 36
###begin title 37
TCR avidity and CD28 co-stimulation regulates Th17 development
###end title 37
###begin p 38
###xml 25 27 25 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 374 376 366 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 413 420 401 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g003">Fig. 3A</xref>
###xml 471 472 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 551 558 535 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g003">Fig. 3A</xref>
###xml 687 688 671 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 794 801 778 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g003">Fig. 3B</xref>
###xml 823 824 807 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1284 1285 1268 1269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1387 1393 1371 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g003">Fig 3D</xref>
We next determined the EC50 of anti-CD28 mAb (effective concentration of anti-CD28 mAb resulting in a 50% inhibition of IL-17 secretion) on Th17 differentiation by supplementing CD3-stimulated T cells with increasing doses of mAb. Suppression was observed with concentrations as low as 0.06 microg/ml, Th17 development was almost entirely abrogated at 1 microg/ml and the EC50 of anti-CD28 mAb was 0.1 microg/ml (Fig. 3A, left). The enhancement in IFN-gamma secreting CD4+ T cells was inversely correlated with the frequency of IL-17-producing cells (Fig. 3A, right). To examine whether impairment of IL-17 production with anti-CD28 mAb was dependent on the TCR-signalling intensity, CD4+ T cells were stimulated with titrated doses of anti-CD3 and a fixed amount of anti-CD28 mAb. As shown in Fig. 3B the percentage of CD4+ T cells producing IL-17 was significatively augmented with high doses of immobilized anti-CD3 mAb. Moreover, the strongest CD28 inhibitory signal for Th17 differentiation was delivered to T cells stimulated with high anti-CD3 concentration. This inhibition of Th17 differentiation could not be attributed to increased cell death. Indeed, the recovery of viable cells as well as apoptotic cell death rate were similar in CD3 and CD3 plus CD28 co-stimulated CD4+ T cells cultures from the early (48 h) to a late time point of restimulation (between 96 and 120 h) (Fig 3D).
###end p 38
###begin title 39
TCR avidity and CD28 co-stimulation signals regulate Th17 development.
###end title 39
###begin p 40
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 292 293 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 524 525 510 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 725 726 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1111 1112 1081 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
(A) Purified CD4+ T were stimulated with plate-bound anti-CD3 (5 microg/ml) and titrated doses of soluble anti-CD28 mAb under Th17 polarizing conditions. Cells were stained intracellularly for IL-17 and IFN-gamma expression. The data shown is one representative experiment out of two. (B) CD4+ T cells were stimulated with titrated doses of plate-bound anti-CD3 in the presence or absence of soluble anti-CD28 mAb (2 microg/ml). Data represent the mean+/-SD of four independent experiments. (C) Cumulative data of viable CD4+ T cell recovery after stimulation with anti-CD3 (5 microg/ml) the presence or absence of anti-CD28 mAb (2 microg/ml). Data are the mean+/-SD of 3 (LNs) to 20 (spleen) independent experiments. (D) CD4+ T cells were stimulated with coated anti-CD3 (10 microg/ml) in the presence or absence of soluble anti-CD28 under Th17 conditions and analyzed at different time points for the percentage of apoptotic cells (Annexin V binding positivity). Mean values+/-SD obtained from at least three separate experiments are presented. P values were calculated using the two-tailed, paired Student's t test, *, P<0.05; **, P<0.01.
###end p 40
###begin title 41
CD28 co-stimulation inhibits Th17 differentiation via IFN-gamma and IL-2-dependent mechanisms
###end title 41
###begin p 42
###xml 124 125 120 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 134 138 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Jenkins1">[20]</xref>
###xml 218 225 214 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g004">Fig. 4A</xref>
###xml 290 291 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 301 307 293 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g001">Fig. 1</xref>
###xml 312 313 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g003">3</xref>
###xml 507 508 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 511 512 499 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 746 753 730 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g004">Fig. 4B</xref>
CD28 signalling is reported to enhance cytokine production that includes IL-2, IL-4 and IFN-gamma secretion in activated CD4+ T cells [20], we found that anti-CD28 mAb increased the proportion of IL-2-producing cells (Fig. 4A) as well as IFN-gamma-producing cells in anti-CD3-stimulated CD4+ T cells (Fig. 1 and 3). Under Th17 polarizing conditions, neutralization of IL-2 or IFN-gamma but not IL-4 partially overcame CD28 blockade and lead to increased IL-17 production. Nonetheless, the frequency of IL-17+CD4+ T cells remained inferior to that generated in the absence of CD28 co-stimulation. However, treatment with both anti-IL-2 and anti-IFN-gamma mAbs restored IL-17 production and thus completely abrogated the effect of CD28 engagement (Fig. 4B).
###end p 42
###begin title 43
The CD28-driven inhibition of Th17 differentiation is mediated by IL-2 and IFN-gamma production.
###end title 43
###begin p 44
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 181 182 181 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 247 248 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 592 593 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 306 311 <span type="species:ncbi:10090">mouse</span>
Purified CD4+ T cells were stimulated with plate-bound anti-CD3 in the presence or the absence of soluble anti-CD28 mAb under Th17 polarizing conditions. (A) The percentages of IL-2+CD4+ T cells from 7 independent experiments (mean+/-SEM). (B) CD4+ T cells were cultured in the presence or absence of anti-mouse IL-4, IFN-gamma or IL-2 alone or in combination. The data shown are representative of 1 experiment out of 3 (dot plots, left panel). The cumulative data from 2-6 independent experiments are shown in the right panel. P values were calculated using the two-tailed, paired Student's t test, *, P<0.05; **, P<0.01; ***, P<0.001.
###end p 44
###begin p 45
###xml 178 179 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 231 232 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 235 236 235 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 304 311 304 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g005">Fig. 5A</xref>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 434 435 434 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 497 504 497 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g005">Fig. 5B</xref>
###xml 566 567 566 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 571 572 571 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 600 601 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 605 606 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 640 641 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 645 646 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 651 652 651 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 881 888 881 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g002">Fig. 2A</xref>
###xml 976 977 976 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 982 983 982 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 992 993 992 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 998 999 998 999 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1043 1044 1043 1044 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1081 1088 1081 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g005">Fig. 5C</xref>
###xml 1088 1089 1088 1089 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
Since IL-2 partly mediated the inhibitory effect of anti-CD28 mAb on Th17 development, we postulated that the suppressive function of IL-2 operates through the expansion of Foxp3+ T cells. We here found that the percentage of Foxp3+CD4+ T cells was decreased rather than increased after CD28 signalling (Fig. 5A). We next directly addressed the contribution of Treg to the CD28-mediated suppression of Th17 differentiation by CD25+CD4+ T cell depletion and reconstitution experimental approaches (Fig. 5B). The IL-17 production was reduced in anti-CD3-stimulated CD4+CD25- T cells. Co-cultures of CD4+CD25- T cells and Treg at different CD4+CD25-/CD25+ T cells ratio enhanced Th17 differentiation. Of notes, Treg were recovered at lower proportion than expected at the end of the cultures that may be best explained by the overwhelming non Treg cell proliferation in the cultures (Fig. 2A and data not shown). Nonetheless, anti-CD28 mAb did not increase the frequency of IL-17+Foxp3+ or IL-17+Foxp3- cells that were almost undetectable in CD25+ T cell-depleted polarised cultures (Fig. 5C).
###end p 45
###begin title 46
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Inhibition of Th17 differentiation by anti-CD28 mAb is not correlated with a expansion of Foxp3+ T cells.
###end title 46
###begin p 47
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 181 182 181 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 256 257 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 262 263 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 267 268 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 306 307 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 333 334 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 339 340 339 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 455 456 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 621 622 617 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Purified CD4+ T cells were stimulated with plate-bound anti-CD3 in the presence or the absence of soluble anti-CD28 mAb under Th17 polarizing conditions. (A) The proportion of Foxp3+CD4+ T cells. Data from 8 independent experiments are shown. (B and C) CD4+, CD4+CD25- T cells and CD4+CD25- T plus CD4+CD25+ T cells (at 1/1, 4/1 CD25-/CD25+ T cell ratios) were stimulated as described. Numbers indicate the percentage of IL-17 and IFN-gamma-expressing CD4+ T cells (B) and IL-17 and Foxp3-expressing cells (C). One of 2 representative experiments is shown. P values were calculated using the two-tailed, paired Student's t test, **, P<0.01.
###end p 47
###begin title 48
Mature DC inefficiently support Th17 differentiation
###end title 48
###begin p 49
###xml 322 329 322 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g006">Fig. 6A</xref>
###xml 355 356 355 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 416 428 416 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g006">Fig. 6B to E</xref>
###xml 522 523 522 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 718 730 714 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g006">Fig. 6B to D</xref>
###xml 789 790 785 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 793 794 789 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 847 854 843 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g006">Fig. 6E</xref>
###xml 883 884 879 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1090 1091 1083 1084 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
The observations that Th17 differentiation can be suppressed by high levels of co-stimulation in an APC-free system led us to examine the ability of immature versus mature dendritic cells (DC) to drive Th17 development. Unstimulated (immature) or LPS-stimulated (mature) mitomycin C-treated bone marrow-derived DC (BMDC) (Fig. 6A) were cocultured with CD4+ T cells under Th17 differentiation conditions. As shown in Fig. 6B to E, the maturation status of the BMDC dictated the fate of Th polarization toward Th17. When CD4+ T cells were differentiated in the presence of mature BMDC, we observed a significant decrease in the percentage of Th17 cells and, as expected, an opposing effect on IFN-gamma producing cells (Fig. 6B to D). Hence, immature BMDC induced higher frequencies of IL-17+CD4+ T cells when compared to their mature counterparts (Fig. 6E). Furthermore, increased CD4+ T cell proliferation was observed with mature BMDC under Th17 polarizing conditions containing TGF-beta, suggesting that the inhibition of IL-17 secretion was unlikely related to a reduced expansion of CD4+ T cells (data not shown).
###end p 49
###begin title 50
Mature BMDC inefficiently support Th17 differentiation.
###end title 50
###begin p 51
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 493 494 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 693 694 679 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 707 708 689 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 724 725 706 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 742 743 724 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 759 760 741 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 833 834 815 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1005 1006 985 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
CD4+ T cells were cultured with immature or mature BMDC at a 2/1 CD4+/BMDC ratio in the presence of anti-CD3 under Th17 conditions. (A) BMDC were stimulated with LPS (1 microg/ml) and stained for CD40, CD86, or MHCII (IA/IE) expression. The mean fluorescence intensity are shown. Data are representative of one experiment out of three. (B) Cells were stained intracellularly for IL-17 and IFN-gamma. Shown is one representative experiment out of 6. (C) Cumulative data of the percentage of CD4+IL-17 and IFN-gamma positive T cells after restimulation as assessed by intracytoplasmic staining. Data represent the mean+/-SEM of 6 independent experiments. (D) The ratio of the percentage of IL-17+ to IFN-gamma+ cells among CD4+ T cells. (E) CD4+ T cells (2.5x105 cells) were cultured with immature or mature BMDC at three different CD4+/BMDC ratios (2/1; 1/1; 1/2) as described in A. Data represent the mean+/-SD of 4 independent experiments. P values were calculated using the two-tailed, paired Student's t test, *, P<0.05; **, P<0.01; ***, P<0.001.
###end p 51
###begin title 52
CTLA4-Ig enhances Th-17 differentiation
###end title 52
###begin p 53
###xml 147 148 147 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 351 352 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 355 356 355 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 366 372 366 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g007">Fig. 7</xref>
###xml 433 434 433 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 484 485 484 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
To evaluate the role of B7.1 and B7.2 co-stimulatory molecules on Th17 differentiation, we used CTLA4-Ig, which interrupts the CD28/B7 pathway. CD4+ T cells were co-cultured with graded numbers of mature-BMDC under Th17 polarizing conditions in the presence or absence of CTLA4-Ig. We found that CTLA4-Ig significantly augmented the frequency of IL-17+CD4+ T cells (Fig. 7, A and B). The proportion of IL-17-producing cells among CD4+ T cells co-cultured with mature BMDC at a 1/1 CD4+/DC ratio in the presence of CTLA4-Ig was similar to the percentage induced with half the number of DC and in the absence of CTLA4-Ig. Thus, lowering the mature DC/T cell ratio or interrupting B7 costimulatory pathways favoured Th17 differentiation.
###end p 53
###begin title 54
CTLA4-Ig favours Th17 development.
###end title 54
###begin p 55
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 212 213 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 348 349 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 449 450 439 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 930 931 912 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 434 439 <span type="species:ncbi:9606">Human</span>
(A) CD4+ T cells were cultured with mature BMDC at three different CD4+/mBMDC ratios (2/1; 1/1; 1/2) in the presence of anti-CD3 under Th17 conditions. CTLA4-Ig (20 microg/ml) was added to cultures with a 1/1 CD4+/mBMDC cell ratio. Cells were stained intracellularly for IL-17 and IFN-gamma. Shown is one representative experiment out of 4. (B) CD4+ T cells were stimulated as in A. Data represent the mean+/-SD of 4 experiments. (C) Human naive CD4+ T cells were co-cultured with activated monocyte-derived DC in the presence or absence of CTLA4-Ig (5 microg/ml), expanded in IL-2 and restimulated. IL-17, IL-22 and IFN-gamma secretion was assessed in the culture supernatants and cells were stained for intracellular IL-17. Shown are 3 independent experiments (ELISA, left panel) and 1 representative out of 3 experiments (intracytoplasmic staining, right panel). P values were calculated using the two-tailed, paired Student's t test, *, P<0.05; **, P<0.01.
###end p 55
###begin p 56
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-AcostaRodriguez1">[21]</xref>
###xml 256 257 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 260 261 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 485 486 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 576 584 572 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 626 627 622 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 641 648 637 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005087-g007">Fig. 7C</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 570 575 <span type="species:ncbi:9606">human</span>
###xml 613 619 <span type="species:ncbi:10090">murine</span>
Human monocytes and conventional DC, but not monocytes-derived DCs activated by microbial stimuli, induced Th-17 priming [21].We therefore determined whether CTLA4-Ig enhanced human Th17 differentiation in APC/T cells co-cultures. To this end, adult CD45RA+CD4+ T cells were cultured with mature monocyte-derived DC in the presence or absence of CTLA4-Ig but in the absence of exogenous cytokines or anti-IFN-gamma mAb. Our data indicate that CTLA4-Ig significantly increased naive CD4+ T cell differentiation into IL-17 and IL-22-producing cells, thereby confirming in human in vitro studies our observations in murine DC/CD4+ co-cultures (Fig. 7C).
###end p 56
###begin title 57
Discussion
###end title 57
###begin p 58
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 233 241 233 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
In this study, we provide strong evidence for an inhibitory role of CD28 in the development of naive CD4+ T cells into IL-17-producing T helper cells with no modulation of IL-17 expression in memory CD4+ T cells. We here demonstrate in vitro that ligation of CD28 with a monoclonal antibody results in inhibition of Th17 differentiation whereas CTLA4-Ig blockade enhances it during APC/T cell interactions. The extent of suppression of Th17 differentiation was regulated by the strength of TCR and co-stimulatory signals.
###end p 58
###begin p 59
###xml 465 466 465 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
We explored some of the cellular mechanisms whereby CD28 engagement inhibited Th17 differentiation. CD28 co-stimulation decreased the frequency of Th17 proliferating cells without reducing their rate of cell division. Moreover, anti-CD28 mAb did not augment early or late apoptosis in anti-CD3-stimulated T cells cultures. Since CD28 signalling did not alter the recovery of viable cells at the end of the cultures, we propose that the decreased proportion of IL-17+ cells may result from an impairment of Th17 differentiation or an arrest of IL-17 production by Th17 proliferating cells. However, CD28 ligation during secondary cultures did not suppress but rather significantly enhanced IL-17 production in Th17 differentiated cells.
###end p 59
###begin p 60
###xml 375 378 365 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Park1">[5]</xref>
###xml 380 384 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Murphy1">[22]</xref>
###xml 386 390 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Harrington1">[23]</xref>
###xml 462 463 448 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 472 476 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Jenkins1">[20]</xref>
###xml 581 582 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 871 875 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Laurence1">[24]</xref>
###xml 877 881 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Kimura1">[25]</xref>
###xml 979 983 953 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Stumhofer1">[26]</xref>
###xml 1256 1260 1230 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Laurence1">[24]</xref>
###xml 1262 1266 1236 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Suzuki1">[27]</xref>
###xml 1382 1386 1356 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Shevach1">[28]</xref>
Although the importance of IL-6, TGF-beta, IL-21 and IL-23 in Th17 development has been clearly established, less is known about physiological antagonists of Th17 responses. Th1 and Th2 cytokines negatively regulate the differentiation of Th17 cells. The addition of IL-12, IFN-gamma or IL-4 suppresses either IL-23 or TGF-beta and IL-6-induced differentiation of Th17 cells [5], [22], [23]. CD28 signalling enhances IFN-gamma and IL-2 secretion in activated CD4+ T cells [20]. In agreement with these observations, we found that the enhancement in IFN-gamma and IL-2-secreting CD4+ T cells was inversely correlated with the frequency of IL-17-producing cells. IFN-gamma neutralization partially overcame CD28-mediated Th17 suppression. When combined, anti-IL-2 and anti-IFN-gamma mAbs abrogated the effect of CD28 engagement. IL-2 and IL-27 inhibit Th17 differentiation [24], [25]. IL-27 can suppress the development of Th17 responses at least by inducing IL-10-producing cells [26]. The percentage of IL-10-secreting cells was low and not altered by CD28 co-stimulation (data not shown). IL-2 is a well-known T cell growth factor, yet, IL-2 deficiency is associated with severe multi-organ autoimmune disease characterised by the overproduction of IL-17 [24], [27]. These observations lead to the findings that IL-2 inhibits Th17 differentiation and promotes Treg differentiation [28].
###end p 60
###begin p 61
###xml 271 272 268 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 276 277 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 286 294 283 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 299 306 296 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 306 310 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Mucida1">[29]</xref>
###xml 312 316 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Zheng1">[30]</xref>
###xml 318 322 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Chen1">[31]</xref>
###xml 425 429 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Benson1">[32]</xref>
###xml 507 508 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 734 737 725 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Bettelli2">[6]</xref>
###xml 739 742 730 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Veldhoen1">[8]</xref>
###xml 744 748 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Xu1">[33]</xref>
###xml 897 901 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-LeibundGutLandmann1">[34]</xref>
###xml 971 975 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Radhakrishnan1">[35]</xref>
###xml 1092 1099 1080 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1099 1103 1087 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Li1">[36]</xref>
###xml 1280 1287 1265 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1598 1602 1583 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Stromnes1">[37]</xref>
###xml 1604 1608 1589 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Steinman1">[38]</xref>
In addition to the thymus-derived naturally occurring regulatory T cells (nTreg), naive T cells can acquire Foxp3 expression and differentiate into induced Treg cells (iTreg) in peripheral tissues. TGF-beta induces Foxp3 expression and iTreg cell differentiation from CD4+CD25- T cells in vitro and in vivo[29], [30], [31]. Co-stimulation through CD28 impairs TGF-beta mediated induction of Foxp3 expression in naive T cells [32]. Our data indicate that CD28 co-stimulation decreased the percentage of Foxp3+ T cells under Th17 conditions. Although Th17 and Treg differentiation are controlled by reciprocal molecular pathways, naive T cells activated with TGF-beta and IL-6 can differentiate into Th17 cells in the presence of nTreg [6], [8], [33]. Our results are consistent with reports showing that Treg cells facilitate the differentiation of Th17 cells in a pro-inflammatory cytokine milieu [34]. Furthermore, regulatory T cells can be reprogrammed into Th17 cells [35]. T cells producing TGF-beta that promote Th17 cell differentiation are absolutely required for the induction of EAE in vivo[36]. During an extracellular pathogen-driven inflammation, TGF-beta (Treg) suppresses Th1 and Th2 differentiation and IL-6 impairs effector T cell responsiveness to Treg, allowing de novo differentiation of protective IL-17-producing T cells from naive precursors. At the same time, CD28 co-stimulation may somehow limit Th17 differentiation to attenuate tissue damage. Nonetheless, since CD28 engagement alters the Th17/Th1 ratio toward Th1, under some circumstances it may aggravate autoimmunity [37], [38]. Taken together, in a Th17-promoting milieu, CD28 co-stimulation augments IFN-gamma and IL-2 production and impairs Th17 polarization.
###end p 61
###begin p 62
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Butte1">[39]</xref>
###xml 500 508 500 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 689 696 689 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 696 700 696 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Suntharalingam1">[40]</xref>
###xml 840 843 840 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 857 861 857 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Jabs1">[41]</xref>
###xml 1121 1122 1121 1122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1258 1261 1258 1261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1328 1331 1328 1331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1463 1467 1463 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Perrin2">[42]</xref>
###xml 1542 1546 1542 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Kolls1">[43]</xref>
###xml 1637 1641 1637 1641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Salomon2">[44]</xref>
###xml 1749 1769 1749 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Borrelia burgdorferi</italic>
###xml 1829 1849 1829 1849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Borrelia burgdorferi</italic>
###xml 1916 1920 1916 1920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Burchill1">[45]</xref>
###xml 1922 1926 1922 1926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Kotloski1">[46]</xref>
###xml 1928 1932 1928 1932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Iliopoulou1">[47]</xref>
###xml 2092 2093 2092 2093 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2099 2103 2099 2103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 2110 2114 2110 2114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Kim1">[48]</xref>
###xml 2116 2120 2116 2120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Hue1">[49]</xref>
###xml 2287 2291 2287 2291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Abrams1">[50]</xref>
###xml 2361 2362 2361 2362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2452 2460 2452 2460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2510 2511 2510 2511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2969 2973 2969 2973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-StClair1">[51]</xref>
###xml 2975 2979 2975 2979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005087-Schraven1">[52]</xref>
###xml 737 741 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
###xml 1271 1275 <span type="species:ncbi:10090">mice</span>
###xml 1340 1344 <span type="species:ncbi:10090">mice</span>
###xml 1573 1577 <span type="species:ncbi:10090">mice</span>
###xml 1728 1732 <span type="species:ncbi:10090">mice</span>
###xml 1749 1769 <span type="species:ncbi:139">Borrelia burgdorferi</span>
###xml 1829 1849 <span type="species:ncbi:139">Borrelia burgdorferi</span>
###xml 2182 2187 <span type="species:ncbi:9606">human</span>
###xml 2346 2351 <span type="species:ncbi:9606">human</span>
###xml 2446 2451 <span type="species:ncbi:9606">human</span>
###xml 2497 2503 <span type="species:ncbi:10090">murine</span>
###xml 2614 2619 <span type="species:ncbi:9606">human</span>
###xml 2650 2655 <span type="species:ncbi:9606">human</span>
We next found that mature DC were less efficient than immature DC at driving Th17 polarization and that CTLA4-Ig favoured Th17 differentiation. These data strongly suggest that B7.1 and B7.2 are involved in the regulation of Th17 differentiation but do not exclude the role of additional pairs of co-stimulatory/inhibitory molecules. Hence, other co-stimulatory molecules may override the absence of B7 co-stimulation for T cell activation and differentiation into Th17 cells [39]. In support of our in vitro observations, several studies have demonstrated that interfering with B7 co-stimulatory pathways may alter the development or the course of Th17/Th1-associated autoimmune diseases in vivo[40]. Notably, B7.1/B7.2 deletion in SJL mice increases their susceptibility to EAE in contrast with the resistance to EAE observed in B7.1/B7.2-/- C57BL/6 mice [41], suggesting that genetic background and B7 costimulatory molecules may dictate the outcome of the Th17 responses in absence of costimulation. In that regard, our unpublished observations indicated that anti-CD28 mAb significantly alter anti-CD3 stimulated CD4+ T cell differentiation into Th17 in BALB/c but not C57BL/6 mice (data not shown). In addition, while MOG induces EAE in wild type (CD28+/+) C57BL/6 mice, it induces immune-mediated meningitis (EAM) in CD28-/- C57BL/6 mice, which is characterized by an infiltrate within the leptomeninges composed primarily of polymorphonuclear neutrophils [42]. T cell-derived IL-17 mediates the stimulation of neutrophil mobilization [43]. Also, B7-2-deficient NOD mice spontaneously develop autoimmune peripheral polyneuropathy [44]. Furthermore, inhibition of IL-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi, while CD28 deficiency exacerbates joint inflammation upon Borrelia burgdorferi infection, resulting in the development of chronic Lyme arthritis [45], [46], [47]. Finally, reduced co-stimulation in either B7.1 or B7.2-deficient recipients resulted in a dramatic acceleration of colitis induction following transfer of CD4+CD45RBhigh cells [48], [49]. Recently, the efficacy of CTLA4-Ig has been investigated in human clinical trials to prevent transplant rejection, and in the treatment of RA and psoriasis vulgaris [50]. We here showed that CTLA4-Ig significantly increased human naive CD4+ T cell differentiation into IL-17 and IL-22-producing cells, thereby confirming in human in vitro studies our present observations in murine DC/CD4+ T cell co-cultures. These findings revealed the importance of B7.1 and B7.2 as negative regulators of human Th17 development. Considering human genetic variability, different individuals may have distinct requirements for costimulatory molecules to control Th17 development and the pathogenesis of autoimmune diseases. Thus, our data invoke caution when interfering with B7 co-stimulatory pathways for therapies, a concept largely debated in the literature [51], [52].
###end p 62
###begin p 63
###xml 139 147 139 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 218 226 <span type="species:ncbi:9606">patients</span>
In conclusion, we identified an unexpected role for the B7/CD28 pathway in the regulation of Th17-associated inflammatory responses. These in vitro observations should be taken into consideration for the management of patients under B7-based immunotherapy for the treatment of autoimmune diseases and other immune-mediated disorders.
###end p 63
###begin p 64
We are grateful to Dr Mohamed Oukka for critical review of the manuscript and helpful comments.
###end p 64
###begin title 65
References
###end title 65
###begin article-title 66
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis.
###end article-title 66
###begin article-title 67
###xml 45 53 <span type="species:ncbi:9606">patients</span>
High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism.
###end article-title 67
###begin article-title 68
Increased expression of interleukin 17 in inflammatory bowel disease.
###end article-title 68
###begin article-title 69
Induction and effector functions of T(H)17 cells.
###end article-title 69
###begin article-title 70
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.
###end article-title 70
###begin article-title 71
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
###end article-title 71
###begin article-title 72
Transforming growth factor-beta induces development of the T(H)17 lineage.
###end article-title 72
###begin article-title 73
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.
###end article-title 73
###begin article-title 74
Th17: an effector CD4 T cell lineage with regulatory T cell ties.
###end article-title 74
###begin article-title 75
IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells.
###end article-title 75
###begin article-title 76
T-cell costimulation-biology, therapeutic potential, and challenges.
###end article-title 76
###begin article-title 77
B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
###end article-title 77
###begin article-title 78
CTLA-4: new insights into its biological function and use in tumor immunotherapy.
###end article-title 78
###begin article-title 79
Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.
###end article-title 79
###begin article-title 80
Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis.
###end article-title 80
###begin article-title 81
The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens.
###end article-title 81
###begin article-title 82
CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes.
###end article-title 82
###begin article-title 83
###xml 48 55 <span type="species:ncbi:9606">patient</span>
Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis.
###end article-title 83
###begin article-title 84
Expression of the self-marker CD47 on dendritic cells governs their trafficking to secondary lymphoid organs.
###end article-title 84
###begin article-title 85
###xml 85 90 <span type="species:ncbi:9606">human</span>
CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells.
###end article-title 85
###begin article-title 86
###xml 131 136 <span type="species:ncbi:9606">human</span>
Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.
###end article-title 86
###begin article-title 87
Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.
###end article-title 87
###begin article-title 88
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.
###end article-title 88
###begin article-title 89
Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation.
###end article-title 89
###begin article-title 90
IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells.
###end article-title 90
###begin article-title 91
Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system.
###end article-title 91
###begin article-title 92
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta.
###end article-title 92
###begin article-title 93
The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells.
###end article-title 93
###begin article-title 94
Oral tolerance in the absence of naturally occurring Tregs.
###end article-title 94
###begin article-title 95
IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells.
###end article-title 95
###begin article-title 96
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
###end article-title 96
###begin article-title 97
All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation.
###end article-title 97
###begin article-title 98
Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta.
###end article-title 98
###begin article-title 99
Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17.
###end article-title 99
###begin article-title 100
Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo.
###end article-title 100
###begin article-title 101
T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.
###end article-title 101
###begin article-title 102
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.
###end article-title 102
###begin article-title 103
A rush to judgment on Th17.
###end article-title 103
###begin article-title 104
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
###end article-title 104
###begin article-title 105
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.
###end article-title 105
###begin article-title 106
Genetic background determines the requirement for B7 costimulation in induction of autoimmunity.
###end article-title 106
###begin article-title 107
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Experimental autoimmune meningitis: a novel neurological disease in CD28-deficient mice.
###end article-title 107
###begin article-title 108
Interleukin-17 family members and inflammation.
###end article-title 108
###begin article-title 109
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice.
###end article-title 109
###begin article-title 110
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 102 122 <span type="species:ncbi:139">Borrelia burgdorferi</span>
Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi.
###end article-title 110
###begin article-title 111
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with borrelia species.
###end article-title 111
###begin article-title 112
###xml 52 72 <span type="species:ncbi:139">Borrelia burgdorferi</span>
CD28 deficiency exacerbates joint inflammation upon Borrelia burgdorferi infection, resulting in the development of chronic Lyme arthritis.
###end article-title 112
###begin article-title 113
Paradoxical effect of reduced costimulation in T cell-mediated colitis.
###end article-title 113
###begin article-title 114
Interleukin-23 drives innate and T cell-mediated intestinal inflammation.
###end article-title 114
###begin article-title 115
###xml 53 61 <span type="species:ncbi:9606">patients</span>
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.
###end article-title 115
###begin article-title 116
The calm after the cytokine storm: lessons from the TGN1412 trial.
###end article-title 116
###begin article-title 117
###xml 49 55 <span type="species:ncbi:9606">humans</span>
CD28 superagonists: what makes the difference in humans?
###end article-title 117
###begin p 118
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 118
###begin p 119
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grant from the Canadian Institute for Health and Research (CIHR Grant, MOP-53152). S.B. is a recipient of the Canadian Institutes for health Research/Canada Graduate Scholarships Doctoral Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 119

